SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000078003-22-000024
Filing Date
2022-02-14
Accepted
2022-02-14 16:04:09
Documents
2
Group Members
PFIZER VENTURE INVESTMENTS LLCPFIZER VENTURES (US) LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G EFFECTOR THEREAPEUTICS effector13g_2x2022vf.htm SC 13G 61325
2 EX-99.1 JOINT FILING AGREEMENT effector_sc13ga1xexhx99x1.htm EX-99.1 9009
  Complete submission text file 0000078003-22-000024.txt   72118
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filed by) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116 2157319450
eFFECTOR Therapeutics, Inc. (Subject) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91982 | Film No.: 22631277
SIC: 2834 Pharmaceutical Preparations